| 标题 |
Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Rheumatology 作者:Philip G Conaghan; Miroslawa Nowak; Shuyan Du; Yi Luo; Jessica Landis; et al 出版日期:2023-04-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)